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Objective: To review the published clinical data in Telerobotic ENT-Head and Neck surgery, evaluate the
beneﬁt of existing clinical applications and identify areas for potential development.
Methods: A qualitative review was performed of publications in PubMed, Medline and the Cochrane
Database identiﬁed from the following keyword searches: Telerobotic/Robotic ENT, Otorhinolaryngology,
Head and Neck surgery, Thyroid and Parathyroid surgery. Preclinical studies and non-clinical review
articles were excluded.
Results: Forty-ﬁve publications were identiﬁed including 7 review articles. Transoral robotic surgery
(TORS) was reported in 20 clinical studies, robotic-assisted thyroidectomy in 13 studies, para-
thyroidectomy in 4 studies and skull base surgery in 1 study. The majority of TORS publications relate to
oropharyngeal malignancy which were Stage III and IV. Clinical beneﬁts include avoidance or dose
reduction of adjuvant chemoradiotherapy and improved swallow function. The primary clinical advan-
tage of robotic-assisted neck surgery is the avoidance of a neck scar. The learning curve for robotic
thyroidectomy is 50 cases. Body habitus is an important factor for assessment of robotic feasibility in
transoral and neck surgery.
Conclusion: The application of robotic-assisted parathyroidectomy, thyroidectomy and TORS suggests
promising improvements in patient care. Randomised control trials are needed to assess clinical
outcome, cost effectiveness and patient beneﬁt in the existing applications. Continued development of
robotic technology will expand the viable clinical applications in this specialty.
 2011 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Telerobotic surgery was developed by NASA in 2001 and initially
envisaged for use in the battleﬁeld by the US Department of
Defence. Over the last decade it has become the established clinical
practice in several surgical specialties. Imperial College London has
been at the forefront of developing and assessing clinical applica-
tions in the UK since 2004.1e3
The daVinci surgical system is a mastereslave Telerobotic plat-
formwhich consists of a console, surgical cart andmanipulator unit
(Fig. 1). The console surgeon views a three-dimensional magniﬁed
image and controls 4 endowristed robotic arms which enhanceHospital, Imperial College
Tel.: þ44 07976 897 446; fax:
).
ciates Ltd. Published by Elsevier Ltmanual dexterity.4 The surgeon’s hand movements are motion
scaled and physiological hand tremor is abolished. The ability to
recreate an open surgical experience, minimise surgical trauma and
improve precision are the primary advantages. This has translated
to improved patient care in several specialties including urology,
gynaecology, cardiothoracic and paediatric surgery.5,6
In ENT-Head and Neck surgery the existing endoscopic tech-
niques have several limitations. In transoral surgery, this includes
a conﬁned operative ﬁeld, limited range of instrument motion, line
of sight issues and poor depth perception.
In endoscopic thyroid and parathyroid surgery limitations
include video camera platform instability, restricted motion of
straight endoscopic instruments, 2-dimensional imaging and
suboptimal operator ergonomics.7
Robotic surgery has the potential to improve patient care in ENT
similar to that witnessed in other specialties. However, the inherent
anatomical constraints which do not occur in open cavities such asd. All rights reserved.
Fig. 1. daVinci SI system.
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REVIEWthe abdomen, pelvis or thorax create unique technical challenges.
Signiﬁcant adaptation to the positioning of the robotic arms and
operating room reconﬁguration is necessary. The essential
preclinical transoral robotic surgery (TORS) studies were per-
formed by Weinstein et al. in 2005.8 An increasing number of
clinical applications have subsequently been reported in TORS
(Fig. 2).
The primary focus of the robotic ENT programme at Imperial
CollegeHealthcareNHSTrustover the last18monthswastodeviseand
evaluate a robotic-assisted parathyroidectomy (RAP) techniquewhich
avoids aneck scar to treatpatientswithPrimaryHyperparathyroidism.
The purpose of this review is to evaluate the existing clinical
applications, assess their advantages in terms of patient beneﬁt and
identify areas for potential application in ENT-Head and Neck
surgery.
2. Methods
A qualitative review was performed of articles in the English language
following keyword searches of PubMed, Medline and the Cochrane Database. The
search terms used were; Telerobotic/robotic/robotic-assisted otorhinolaryngology,
ENT, head and neck, thyroid and parathyroid surgery. These included prospectiveFig. 2. TORS clinical publications 2005e2010.clinical trials, case series and case reports. Preclinical studies (cadaveric and
animal studies) and non-clinical review articles were excluded. The speciﬁc
aspects which were evaluated included existing clinical applications and feasi-
bility, exclusion criteria, morbidity, mortality, length of stay, cost and the
learning curve.
The references of relevant papers were evaluated as a source of further study.
Personal communication of unpublished clinical data was sought from three experts
in the ﬁeld of ENT-Head and Neck surgery (N Tolley, C Vicini and G Weinstein) and
from the American Cancer Society Department of Surveillance and Health Policy
Research.
3. Results
Therewere 45 publications all within the last 5 years comprising
9 case reports, 29 case series and 7 review articles (Table 1).9e56 Six
case series contained 50 patients or more and the largest series
contained 1043 patients.9e14
The ﬁrst clinical applications were reported in 2005 for
thyroidectomy and TORS to remove a benign oropharyngeal
lesion.15,16 The application of TORS in head and neck cancer was
published the following year.17 TORS accounts for the largest
number of publications (Fig. 3). There are 17 TORS case series/
reports in head and neck cancer and 3 for benign con-
ditions.9,10,16,17e31,32,34 There are 13 case series/reports of robotic-
assisted thyroidectomy11e15,35e44 and 4 case series/reports of
robotic-assisted parathyroidectomy (RAP) all for a mediastinal
adenoma.45e50 A RAP feasibility study of 12 cases has been accepted
for publication. In the other ENT subspecialties, there is 1 case
report of robotic-assisted skull based surgery.51Table 1
Results of literature search: 2005e2010.
Publication type TORS Skull base Thyroid Parathyroid
Benign Malignant
Case report 1 1 1 3 3
Case series 2 16 e 10 1
Review article 5 e 2 e
Total 25 1 15 4
Fig. 3. Robotic clinical publications in ENT-Head & Neck surgery.
Fig. 5. TORS in Head & Neck Cancer: anatomical subsite treated.
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Seventeen studies report 319 cases of oral cavity, oropharyngeal,
hypopharyngeal and laryngeal malignancy treated with
TORS.9,10,17e31 Oropharyngeal and oral cavity cancer account for
85% of cases and the majority of these were stage III or IV disease
(Figs. 4a and 5).
Table 2 summarises the 4 largest TORS studies.9,10,19,22 Mean
follow upwas 13months. Failure due to suboptimal access occurred
in 6.2% of cases. Contributing factors included a narrow mandible,
full dentition, retrognathia and trismus.
Exclusion criteria included lateral or posterior tumour ﬁxation,
tumour adjacent to the carotid artery or involvement of the naso-
pharynx, lateral pterygoid muscle or mandible.
Morbidity: Complications include one neck haematoma neces-
sitating return to theatre and development of an oro-cutaneous
ﬁstula (n ¼ 4). A temporary tracheostomy was performed in 14% of
cases. Moore et al. reported an equal distribution of tracheostomy
irrespective of T stage.9 Predictive factors of poor swallow were anFig. 4. a. Stage distribution of Oropharyngeal & Oral cavity cancer treated with TORS
(Moore,9 Weinstein19 and Boudreaux22). b. T Stage distribution of Oropharyngeal &
Oral cavity cancer treated with TORS.advanced T stage, preoperative nasogastric feeding and recurrent/
2nd primary tumour resection.10 Resumption of oral intake
occurred in approximately 70% of patients within 2 days increasing
to 83% two weeks following surgery. At 12 months, 17% of patients
were percutaneous endoscopic gastrostomy (PEG) tube dependent
as was a similar proportion in the Mayo study. PEG dependent
patients all had T4 disease and 90% of these involved the tongue
base. Weinstein et al. reported a 2.4% PEG dependency rate in
a series of 47 patients with oropharyngeal cancer at a minimum of
12 months follow up.19
Mortality: Perioperative mortality has not been reported.
Recurrence: The Mayo study reported one (2%) contralateral
tongue cancer and three (7%) regional neck recurrences. In Wein-
stein’s largest reported series, local control was achieved in 98%,
regional control in 96% and distant control in 91% of cases at 18
months follow up.19
Adjuvant therapy: The Mayo Clinic group used a smaller dose of
adjuvant chemoradiotherapy than conventionally administered
although their protocol was not stated. In Weinstein’s series, 38% of
patients avoided adjuvant chemotherapy and 11% avoided adjuvant
chemoradiotherapy.19
In a recently updated publication of 31 oropharyngeal cases, 86%
of patients with N1 disease and 30% of patients with N2 disease
avoided concurrent chemotherapy.18 Of the N1 patients, 29% avoi-
ded radiotherapy or any adjuvant therapy altogether.
The application of a ﬂexible CO2 laser with TORS has been
reported in 8 patients with early oropharyngeal or laryngeal
tumours.26,28 Robotic-assisted free ﬂap reconstruction in the oral
cavity and oropharynx was reported in 2 cases.24 Image guided
TORS using the BrainLAB AG navigation system was reported in 1
oropharyngeal and 2 parapharyngeal tumours.27
3.2. TORS: benign head & neck
The ﬁrst clinical application published in 2005 was marsupial-
isation of a vallecular cyst.15 In 2007, its application in paediatric
ENT surgery for laryngeal cleft repair was reported in 2 patients.33
In 2010, Vicini et al. performed tongue base reduction, supra-
glottoplasty and uvulopalatoplasty in 10 patients with obstructive
sleep apnoea or snoring.32 In 8 patients this was in addition to (non
robotic) nasal surgery. All patients had a tracheostomy and naso-
gastric tube insertion. Successful decannulation and normal
swallow function was achieved as was a signiﬁcant reduction in
Epworth score and ApnoeaeHypopnoea Index (AHI) post-
operatively. Patient reported outcome measures included 90%
satisfaction scores.
3.3. Robotic-assisted parathyroidectomy (RAP)
In 2004, Bodner et al. reported robotic-assisted mediastinal
parathyroidectomy using thoracoscopic ports.44e47 The parathyroid
adenoma, located in the aortopulmonary window, was successfully
removed although the patient developed temporary recurrent
laryngeal nerve (RLN) paresis. There are 2 further case reports and 1
Table 2
TORS Head & Neck Oncology: summary of 4 major clinical series.
Level of
evidence
No. of
clinical
cases
Tumour site
(no. of patients)
Exclusions-
unsuitable
access
Mean setup
time
Mean
surgical
time
Blood
loss (ml)
Length
of stay
Follow up
time
Return to normal
swallow (%)
Airway
management
Boudreaux
et al.
200922
III 29 Oral Cavity 2
Oropharynx 19
Hypopharynx 7
Larynx 1
3 N/R 99 min 2e150
(mean
51)
1e13
days
3 months 79% at last follow
up
1planned
tracheostomy
-Decannulated prior
to discharge
5 prolonged
intubation (2 days)
Moore et al.
20099
III 45 Base of tongue
26
Tonsillar Fossa
19
0 1st 10:
68 min
Subsequent:
22 min
71 min N/R 1e10
days
3 months
e2 years
100% at last follow
up
Tracheostomies
intraoperatively: 14
Mean
decannulation at 7
days
Iselia et al.
200910
III 54 Oral cavity 6
Oropharynx 33
Larynx 12
Hypopharynx 3
5 N/R N/R N/R 1e7
days
2 months
e2 years
83% at mean 12
months follow up
Tracheostomies
intraoperatively: 5
Mean
decannulation at 8
days
Weinstein
et al.
201019
IIb 47 Base of tongue
23
Tonsil 23
Soft Palate 1
3 N/R N/R 220 ml
(mean)
N/R Mean:26
months
97.6% at last follow
up
Tracheostomies: 5
3 planned and 2
unplanned
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REVIEWcase series (n ¼ 5) describing the trans-thoracic approach for
mediastinal parathyroidectomy with no complications.48e50
In 2009, Tolley and Arora pioneered a scar-less in the neck
approach when the parathyroid adenoma is located in the neck.
The parathyroid adenoma was successfully removed in 15 cases
with negligible blood loss and 1 conversion. The mean exposure
and robot console times (30 and 45 min respectively) were
affected by body habitus. Subjective voice assessment demon-
strated no voice change and ﬁbreoptic nasendoscopy conﬁrmed
normal vocal cord mobility. All patients were discharged within
24 h. The mean VAS for scar cosmesis was 75% on the ﬁrst day
and improved to 94% at 12 months. Pain decreased to 8% at 2
weeks.
3.4. Robotic-assisted thyroidectomy (RAT)
The literature consists of 3 case reports, 10 case series and 2
review articles.11e15,34e43 The transaxillary robotic technique was
ﬁrst described in 2005 for a hemithyroidectomy in a paediatric
patient.15 In 2008, the same team reported a bilateral axillary
approach for total thyroidectomy in 2 paediatric patients.36
In adults, the largest experience is from South Korea where
Chung et al. pioneered the gasless transaxillary technique. In 2009
they published a preliminary series of 100 cases for patients with
thyroid cancer.11,41 This was followed by a series of 338 patients and
in 2010, a case control study of 41 robotic cases versus conventional
surgery in 43 patients.12,37 There was no signiﬁcant difference
between the two groups for pain, surgical complications and voice
quality. Neck hypersthaesia and swallow disturbance were higher
in the conventional surgery cohort at 3 months. Patient satisfaction
with scar cosmesis was higher in the robotic group at a similar
timeframe. Recently, a Korean multicentre study evaluating the
learning curve in 644 robotic cases was published and the same
group have published a retrospective review of clinical outcome in
1043 cases.13,14
Two other Korean groups have reported slight modiﬁcations to
this transaxillary technique. Tae et al. inserted the 4th arm trocar
through an ipsilateral peri-areolar nipple incision.38 Lee et al. used
a bilateral transaxillary approach with CO2 insufﬂation.40 Table 3
gives an overview of the different techniques and clinical
outcomes of the 4 major series.3.5. Other applications
Skull base surgery has been evaluated in preclinical studies
using a transnasal approach to the sella and TORS to access the
craniocervical junction and atlantoaxial spine.57e60 There is one
case report in the literature.51 TORS has been used to excise 3
parapharyngeal space tumours which avoided the morbidity
associated with splitting the mandible for access.27
4. Discussion
The application of Telerobotics is a new, rapidly evolving ﬁeld in
ENT- Head and Neck surgery. In December 2009 FDA approval was
granted for TORS in the oral cavity, oropharynx, hypopharynx and
larynx.
4.1. TORS
Conventional transoral surgery can be technically challenging
due to suboptimal target visualisation. Conversely, an open
approach can involve debilitating surgery. In TORS, two 5 or 8 mm
wristed instrument arms and a central 3D 8.5 or 12 mm endoscope
are inserted transorally via a Boyle Davis mouth gag or FK retractor.
The instruments are controlled by the console surgeon to perform
multi-planar, en bloc resection. Less blood loss, reduced post-
operative stay and improved functional outcomes have been
reported.9,10,18e22
The majority of TORS cases were in the T1 and T2 category
(Fig. 4b). This is not surprising as approximately 60% of patients
with advanced stage oropharyngeal cancer recorded in the 2007
American National Cancer Database were T1 and T2. This is in
addition to all patients with Stage I and Stage II disease which are,
by deﬁnition, T1 or T2 tumours.61 Regardless of treatment, most
studies of oropharyngeal cancer report that the majority of patients
have T1 and T2 tumours. Therefore, the key issue regarding disease-
speciﬁc survival is not T stage but rather the N stage. This drives the
overall staging in oropharyngeal cancer and determines the need
for adjuvant therapy following TORS or the use of chemotherapy
and radiation if non-surgical therapy is used for the primary
treatment modality. In this regard, the TORS treatment paradigm is
similar to other studies as the vast majority of patients have
advanced Stage III and IV disease.
Table 3
Robotic Thyroidectomy: summary of 4 major clinical series.
Author, institution, year Level of
evidence
Patient
no
Technique Operation type
(n)
Total time
(min)
Tumour size
(cm)
LOS
(days)
Complications (%)
Lee et al., Multicentre study,
201013
III 1043 Gasless Transaxillary Total
Thyroidectomy
(366)
Partial
Thyroidectomy
(677)
132 0.8 2.9 Permanent RLN palsy (0.5%)
Transient RLN paresis (4.3%)
Transient hypocalcemia
(18.4%)
Transient brachial plexus
neuropraxia (0.3%)
Tracheal injury (0.3%)
Horner’s syndrome (0.1%)
Seroma (2%)
Minor chyle leakage (1.2%)
Muscle ﬂap haematoma
(0.5%)
Kang et al., Yonsei University,
200912
III 338 Gasless Transaxillary Total
Thyroidectomy
(104)
Partial
thyroidectomy
(234)
144 0.8 3.3 Permanent RLN injury (0.8%)
Transient RLN paresis (3.8%)
Transient hypocalcemia
(41.3%)
Transient brachial plexus
neuropraxia (0.2%)
Horner syndrome (0.2%)
Seroma (1.7%)
Haematoma (0.6%)
Tae et al., Hanyang University,
201038
III 41 Gasless axillo-breast or
axillary
Total
thyroidectomy
(10)
Partial
Thyroidectomy
(31)
179 1.63 6.4 Transient RLN palsy (2.4%)
Transient hypocalcemia
(20%)
Seroma (4.9%)
Lee et al., Seoul National
University Hospital, 200940
III 15 Bilateral Axillary Breast with
CO2 insufﬂation
Total
Thyroidectomy
(14)
Partial
Thyroidectomy
(1)
218 <1 on pre op
ultrasound
3.5 Nil
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REVIEWWeinstein et al. (University of Pennsylvania) established the ﬁrst
TORS programme in 2004 and have the largest clinical experience.
Preliminary results suggest equivalent rates of loco-regional
recurrence compared with conventional treatment.19,56 Several
meta-analysis studies report that the prognosis for locally advanced
oropharyngeal disease with surgery and/or radiotherapy is 30e35%
at 5 years.62 There is an additional survival beneﬁt with altered
fractionated radiotherapy and concurrent chemotherapy.63,64
Recent studies involving a primary surgical approach for T1 and
T2 tumours with adjuvant radiotherapy when indicated report
local control rates of 87%e98%.65e67 Grant et al. report the 5 year
local control rate for T1eT3 oropharyngeal carcinoma with N0 and
N1 neck disease using transoral laser microsurgery (TLM) alone was
over 90%.68
The University of Pennsylvania have not yet published their 5
year data although at 2 years the disease-speciﬁc survival in 47
patients who underwent TORS was 97%.56 Some of this cohort also
received post operative IMRT (Intensity modulated radiotherapy)
and/or adjuvant chemotherapy. Quon et al. have outlined the
rationale for a trimodality treatment with TORS for oropharyngeal
carcinoma.56 The robotic transoral approach permits en bloc
resection which is not possible with TLM. This improves the ability
to interpret the adequacy of the resection margins which is an
important factor for determining whether adjuvant therapy is
indicated. Compared with open resection TORS is associated with
less morbidity. An additional beneﬁt is the avoidance or dose
reduction of adjuvant radiotherapy and chemotherapy due to clear
resection margins and effective pathological risk stratiﬁcation
which a staged approach to the neck permits.18,56 In patients
treated using TORS with N1 disease in the neck there was an 86%
avoidance of cisplatin postoperatively. This decreased to 30% for N2
disease.The oropharyngeal series reported by Weinstein et al. (n ¼ 47)
comprised entirely of Stage III and IV disease.19 97.6% of patients
swallowed normally at 12 month follow up. Similar outcomes have
been reported in other centres including Moore et al. who reported
a zero PEG dependency rate in their series.9 In comparison, swal-
lowing complications at 2 years following primary chemo-
radiotherapy for oropharyngeal cancer has been reported as
13e43%.69e71 Randomised studies which compare TORS with
established treatments such as transoral laser surgery and primary
chemoradiotherapy are needed to further evaluate these potential
advantages.
4.1.1. Feasibility
Appropriate case selection is important because inadequate
access precludes TORS in at least 6% of cases. Triaging potential
candidates with panendoscopy reduces this ﬁgure.55 Patients with
snoring and obstructive sleep apnoea require a different assess-
ment strategy. A TORSS (transoral robotic sleep surgery) pilot study
conducted at Imperial College London evaluated feasibility in 5
patients. Preoperative sleep nasendoscopy was performed to
identify patients with tongue base collapse most likely to beneﬁt
from a robotic approach.
4.1.2. Future developments
Robotic phonosurgery, subglottic surgery and skull base access
are limited by the existing Telerobotic platform and mouth gags.
Instrument and endoscope miniaturisation is necessary. The
development of robotic technology designed for single port surgery
and multi backbone snake-like robotic units promise to expand
clinical applications.54,72
The combination of ﬂexible CO2 laser with TORS has been
reported.26,28 The laser tip is a few millimetres from the target and
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Advantages include less peripheral thermal injury compared to
monopolar diathermy. However, existing laser ﬁbres are fragile and
require an integrated delivery channel.
Image guided TORShas been shown to facilitate tumour resection.
Guidance is two-dimensional and relies on ﬁxed bony landmarks.
However, the relationship between the soft tissue and these land-
marks can change with excessive patient manipulation; for instance
duringmouth gag insertion. Research is on-going at Imperial College
London to develop an Augmented Reality (AR) three-dimensional
image guidance systemwhich improves surgical accuracy.73
4.2. RAP & RAT
Robotic parathyroid and thyroid surgery use a lateral rather than
the conventional anterior neck approach. In RAT the ipsilateral arm is
abducted at the shoulder to minimise the tunnelling distance
between the axilla and neck. Three robotic arms holding the endo-
scope and two 8mm instruments are introduced through an axillary
incision. A 4th arm, used for thyroid retraction, is inserted through
the same incision or via a separate anterior chest or peri-areolar
breast incision.38,40 The primary advantage is the avoidance of a neck
scar. Scars in visible areas such as the anterior neck have a detri-
mental effect on body image.74 This is supported by ﬁndings in
a robotic thyroidectomy case control study at 3 months.37 The arm
position can cause over-traction and a 0.3% incidence of brachial
plexus neurapraxia is reported in the largest series.14 Temporary
shoulder discomfort was reported in approximately 12% of patients
in another series although there was no difference in pain between
robotic and control thyroidectomy groups.37 Swallow function
appears better with the robotic approach. This may be because the
lateral approach avoids midline strap muscle dissection, para-oeso-
phageal traction is minimal and because 3D magniﬁcation enables
precise tissue manipulation. The 4.3% temporary RLN rate in RAT is
equivalent to conventional surgery. The 0.5% incidence of permanent
RLN palsy is attributed to pathology greater than 6 cm and
thyroiditis. Permanent hypocalcaemiawas not reported although the
incidence of transient hypocalcaemia ranges from 18 to 40%.12,13,38
Blood loss was not recorded but only 5 patients (0.5%) developed
a muscle ﬂap haematoma of which 1 patient required surgical
intervention.13 The preliminary functional outcomes of RAP and RAT
are encouraging. Long term prospective outcome data are imminent
and randomised clinical studies are warranted to evaluate potential
advantages. There is little published in the literaturewhich evaluates
patient perception of scar cosmesis in thyroid and parathyroid
surgery. In the last decade, several scar-less in the neck surgical
approaches have been reported.75e78Whether patients prefer a scar-
less in the neck approach is an important issue in determining
whether these techniques become accepted in parathyroid and
thyroid surgery. The morbidity associated with these approaches
must also be shown to be at least equivalent to the established
minimal access techniques.
4.2.1. Feasibility
Body habitus is a crucial factor for performing successful RAP
and RAT. Patients with an anterior larynx are technically chal-
lenging when a total thyroidectomy is performed robotically due to
difﬁcult access to the contralateral lobe. Thyroiditis and nodules
greater than 6 cm are associated with a higher incidence of RLN
injury.
4.3. The robotic learning curve
The learning curve has implications for patient care, clinical
workload and training.79 Robotic surgery has a shorter process ofskill acquisition compared to endoscopic surgery in other special-
ties.80,81 A prospective multicentre study of robotic thyroidectomy
in 644 cases suggests that the learning curve for total thyroidec-
tomy plateaus after 50 cases.14 The TORS learning curve has not
been formally published although in individual case series, the
setup and docking times reduce as clinical experience grows. The
setup time in the ﬁrst reported case was 75 min compared to 9 min
in Weinstein’s series.16,21
4.4. Robotic training
Effective training models address issues such as lack of haptic
feedback and are essential for optimising surgical outcome.82 The
University of Pennsylvania has an established training programme
in TORS. This includes observation in clinic and the operating
theatre. The laboratory component involves practising stand-
ardised tasks on a virtual reality trainer, porcine models and
surgeon led cadaver training.55
4.5. Cost effectiveness
Cost is a major issue in establishing any clinical robotic pro-
gramme. The initial outlay is £1 million for the da Vinci system in
addition to annual service cost which can be £80,000. This does not
include the costs for consumables which are roughly $200 per case.
Training costs for a robotic surgery unit can be as much as £100,000
depending on the number of individuals. Indirect costs take the
form of prolonged initial operative times which lead to a reduced
caseload.83 These may be off-set by the potential reduction in
hospital admission times and the avoidance of HDU/ITU admis-
sions. Evidence of cost effectiveness in the ENT literature has not
yet been published. In Urology, the health economics associated
with robotic-assisted prostatectomy have been compared with
established techniques.84 The directly measurable outcomes were
not signiﬁcantly improved compared with laparoscopic or open
procedures to off-set the substantial increased cost associated with
robotic surgery. Further research is needed into cost effectiveness
evaluating both direct and indirect potential advantages in ENT
surgery.
4.6. Limitations
It is important to acknowledge the limitations of our method-
ology and also the robotic technology in its present form. This
review only included clinical publications in the English language.
This may introduce exclusion bias and underestimate the number
of cases that were actually performed.
Weinstein et al. imposed strict exclusion criteria for patients
undergoing TORS for oropharyngeal cancer due to the anatomical
restrictions. These relate to the physical size of the instruments and
arms of the daVinci robot.55,56 Despite a reduction in the size of the
original instruments this remains an important limitation in ENT
surgery. Preoperative endoscopy under general anaesthetic was
necessary to identify suitable patients, which represents an addi-
tional procedure.
The lack of haptic feedback is not a major limitation although
this may contribute to the longer initial operating times and the
relatively steep learning curve.17,21,29,55 The time taken to dock the
robot can initially impact and prolong operating times. However,
several groups report that this quickly improves particularly if the
robotic programme contains a sufﬁciently high volume caseload.55
The practical aspect of the theatre space required to facilitate the
use of the daVinci robot is important andmay preclude applications
which involve day-case units where ﬂoor-space may be minimised.
In order for robotic surgery to be cost effective the staff using it will
A. Arora et al. / International Journal of Surgery 9 (2011) 277e284 283
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technical issues. There is not as yet a recognised training pro-
gramme for surgeons or for theatre staff in the UK.
5. Conclusion
The application of Telerobotic-assisted ENT-Head and Neck
surgery facilitates minimal access endoscopic techniques. The
clinical studies reviewed report several potential improvements in
patient care. These include reducing the morbidity associated with
oropharyngeal cancer surgery such as the avoidance of a mandib-
ular split, superior PEG dependence rates/swallow function and
reduced length of hospital admission. In parathyroid and thyroid
surgery, a robotic-assisted technique allows a scar-less in the neck
approach. It also offers a new paradigm for the surgical manage-
ment of patients with obstructive sleep apnoea. Randomised
control trials are needed to evaluate clinical outcome and patient
beneﬁt in existing applications. The cost effectiveness in ENT
applications must be evaluated. A robust framework for training,
assessment and safe implementation is also crucial. The possibility
for expanding the boundaries of minimal access techniques such as
anterior skull base surgery will depend on further instrument and
endoscope miniaturisation. The rapidly evolving ﬁeld of robotic
surgical technology promises to expand the clinical applications in
this specialty. The lasting value of robotic-assisted surgery in
otolaryngology, head and neck surgery remains to be seen.
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